Covalon Technologies (COV) Planet MicroCap Showcase: VANCOUVER 2024 summary

Strategic focus and market positioning

• Emphasis on infection prevention, pain reduction, and healing in med tech, with a shift toward wound care and vascular access segments showing early positive results.

• Solutions address significant clinical challenges, supported by favorable industry trends and protected by patents covering composition and manufacturing.

• Strong presence in the U.S. market, outpacing competitors in growth, with a unique product composition and a focus on high-value hospital segments.

• Competitive landscape features distracted larger players, providing an opportunity to gain market share.

• Key opinion leaders and leading hospitals recognize product value, supporting further adoption.

Operational improvements and turnaround

• Leadership team with deep med tech experience has implemented a turnaround, focusing on right-sizing the commercial team and instilling a quality and compliance culture.

• New processes and a customer-focused culture have driven significant improvements and repaired key relationships.

• Achieved back-to-back profitable quarters after nine consecutive quarters of losses.

Financial performance and growth

• Strong company-wide and U.S. product growth, with U.S. wound care and vascular access sales growing nearly 60% last year and even more this year.

• Improved margins due to insourced manufacturing and favorable product mix, with U.S. margins outperforming international sales.

• Operating expenses reduced as a percentage of revenue, supporting a net income turnaround and positive cash flow.

• Recent warrant exercise added over CAD 5 million, resulting in a strong cash position and no debt.